Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy-Reference-Cited by-同舟云学术

Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy

Published:2016-03 Issue: Volume:56 Page:122-130
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Araki Nobuhito,Takahashi Shunji,Sugiura Hideshi,Ueda Takafumi,Yonemoto Tsukasa,Takahashi Mitsuru,Morioka Hideo,Hiraga Hiroaki,Hiruma Toru,Kunisada Toshiyuki,Matsumine Akihiko,Kawai Akira

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Translocation-related sarcomas;Mertens;Semin Oncol,2009

2. Soft tissue sarcomas of adults: state of the translational science;Borden;Clin Cancer Res,2003

3. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas;Edmonson;J Clin Oncol,1993

4. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group;Santoro;J Clin Oncol,1995

5. Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review;Sharma;BMC Cancer,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials;Cancers;2023-09-15

2. Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis;Frontiers in Oncology;2022-12-08

3. Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond);Future Oncology;2022-10

4. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG);ESMO Open;2022-04

5. Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma;Clinical Sarcoma Research;2020-08-27